Determining the Seasonality of Respiratory Syncytial Virus in Slovenia

Overview

Journal Influenza Other Respir Viruses

Publisher Wiley

Specialty Microbiology

Date 2020 Jul 14

PMID 32656961

Citations 10

Authors

Eva Grilc

Katarina Prosenc Trilar

Jaro Lajovic

Maja Socan

Affiliations

Soon will be listed here.

Abstract

Background: In Slovenia, the respiratory syncytial virus (RSV) surveillance is based on national laboratory data. The weeks with more than 10% of samples tested positive compose RSV epidemic season. The use of real-time multiplex PCR, which identifies other respiratory pathogens in parallel with RSV, caused more testing but the percentage of RSV positives lowered. The 10% threshold was reached with delay, which raised concern about its suitability for defining RSV seasonality.

Methods: To describe the seasonality of RSV, the onset, offset and duration of the RSV epidemic season across 10 years (from week 40, 2008/2009 to week 39, 2017/2018), four calculative methods were deployed including moving epidemic method, MEM, and epidemiological parameters were compared.

Results: In 10 years, 10 969 (12%) out of 90 264 samples tested positive for RSV. The number of tested samples increased remarkably from the first to last season with a drop in the percentage of positive samples from 23% to 10%. The onset of RSV epidemic varied considerably regardless of the calculative method used (from 10 to 13 weeks). The unevenness in the RSV epidemic season end was also observed. The average duration of RSV epidemic season was the shortest when moving epidemic method has been used (15.7 weeks) and longest with ≥3% method (22.9 weeks).

Conclusion: The ≥3% calculative method could be used as an early warning of the RSV season. However, ≥7% calculative method was found to be reliable enough to define the epidemiological parameters of an ongoing season and to support public health response. The potential of the moving epidemic method should be further explored.

Citing Articles

Assessing the Impact of Non-Pharmaceutical Interventions During the COVID-19 Pandemic on RSV Seasonality in Europe.

Heemskerk S, Baliatsas C, Stelma F, Nair H, Paget J, Spreeuwenberg P Influenza Other Respir Viruses. 2025; 19(1):e70066.

PMID: 39838552 PMC: 11750802. DOI: 10.1111/irv.70066.

Use of the moving epidemic method to guide the launch of palivizumab immunization campaigns for respiratory syncytial virus in Québec, Canada.

Raad C, Ouldali N, Lebel M, Paquette M, Gilca R, Papenburg J Can J Public Health. 2024; .

PMID: 39702848 DOI: 10.17269/s41997-024-00985-4.

Variability in the Timing of Respiratory Syncytial Virus Epidemics in Guatemala, 2008-2018.

Hamid S, Grajeda L, de Leon O, Lopez M, Maldonado H, Gomez A Influenza Other Respir Viruses. 2024; 18(7):e13334.

PMID: 38980961 PMC: 11232890. DOI: 10.1111/irv.13334.

The Changing Detection Rate of Respiratory Syncytial Virus in Adults in Western Australia between 2017 and 2023.

Foley D, Minney-Smith C, Tjea A, Nicol M, Levy A, Moore H Viruses. 2024; 16(5).

PMID: 38793538 PMC: 11125702. DOI: 10.3390/v16050656.

Seasonality of respiratory syncytial virus infection in children hospitalized with acute lower respiratory tract infections in Hunan, China, 2013-2022.

Xie L, Wang T, Yu T, Hu X, Yang L, Zhong L Virol J. 2024; 21(1):62.

PMID: 38454522 PMC: 10921640. DOI: 10.1186/s12985-024-02336-8.

References

Vega T, Lozano J, Meerhoff T, Snacken R, Mott J, Ortiz de Lejarazu R . Influenza surveillance in Europe: establishing epidemic thresholds by the moving epidemic method. Influenza Other Respir Viruses. 2012; 7(4):546-58. PMC: 5855152. DOI: 10.1111/j.1750-2659.2012.00422.x. View

Broberg E, Waris M, Johansen K, Snacken R, Penttinen P . Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries, 2010 to 2016. Euro Surveill. 2018; 23(5). PMC: 5801642. DOI: 10.2807/1560-7917.ES.2018.23.5.17-00284. View

Meijer A, Brown C, Hungnes O, Schweiger B, Valette M, van der Werf S . Programme of the Community Network of Reference Laboratories for Human Influenza to improve Influenza Surveillance in Europe. Vaccine. 2006; 24(44-46):6717-23. DOI: 10.1016/j.vaccine.2006.05.068. View

Rose E, Wheatley A, Langley G, Gerber S, Haynes A . Respiratory Syncytial Virus Seasonality - United States, 2014-2017. MMWR Morb Mortal Wkly Rep. 2018; 67(2):71-76. PMC: 5772804. DOI: 10.15585/mmwr.mm6702a4. View

Midgley C, Haynes A, Baumgardner J, Chommanard C, Demas S, Prill M . Determining the Seasonality of Respiratory Syncytial Virus in the United States: The Impact of Increased Molecular Testing. J Infect Dis. 2017; 216(3):345-355. PMC: 5712458. DOI: 10.1093/infdis/jix275. View

Shi T, McAllister D, OBrien K, Simoes E, Madhi S, Gessner B . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017; 390(10098):946-958. PMC: 5592248. DOI: 10.1016/S0140-6736(17)30938-8. View

Reeves R, Hardelid P, Gilbert R, Warburton F, Ellis J, Pebody R . Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007-2012. Influenza Other Respir Viruses. 2017; 11(2):122-129. PMC: 5304572. DOI: 10.1111/irv.12443. View

Mollers M, Barnadas C, Broberg E, Penttinen P, Teirlinck A, Fischer T . Current practices for respiratory syncytial virus surveillance across the EU/EEA Member States, 2017. Euro Surveill. 2019; 24(40). PMC: 6784450. DOI: 10.2807/1560-7917.ES.2019.24.40.1900157. View

Vos L, Teirlinck A, Lozano J, Vega T, Donker G, Hoepelman A . Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017. Euro Surveill. 2019; 24(20). PMC: 6530251. DOI: 10.2807/1560-7917.ES.2019.24.20.1800469. View

10.

Baumeister E, Duque J, Varela T, Palekar R, Couto P, Savy V . Timing of respiratory syncytial virus and influenza epidemic activity in five regions of Argentina, 2007-2016. Influenza Other Respir Viruses. 2018; 13(1):10-17. PMC: 6304310. DOI: 10.1111/irv.12596. View

11.

Janet S, Broad J, Snape M . Respiratory syncytial virus seasonality and its implications on prevention strategies. Hum Vaccin Immunother. 2017; 14(1):234-244. PMC: 5791579. DOI: 10.1080/21645515.2017.1403707. View

12.

Griffiths C, Drews S, Marchant D . Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev. 2016; 30(1):277-319. PMC: 5217795. DOI: 10.1128/CMR.00010-16. View

13.

Obando-Pacheco P, Justicia-Grande A, Rivero-Calle I, Rodriguez-Tenreiro C, Sly P, Ramilo O . Respiratory Syncytial Virus Seasonality: A Global Overview. J Infect Dis. 2018; 217(9):1356-1364. DOI: 10.1093/infdis/jiy056. View

14.

Bont L, Checchia P, Fauroux B, Figueras-Aloy J, Manzoni P, Paes B . Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries. Infect Dis Ther. 2016; 5(3):271-98. PMC: 5019979. DOI: 10.1007/s40121-016-0123-0. View

15.

Mullins J, LaMonte A, Bresee J, Anderson L . Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J. 2003; 22(10):857-62. DOI: 10.1097/01.inf.0000090921.21313.d3. View

16.

Vega T, Lozano J, Meerhoff T, Snacken R, Beaute J, Jorgensen P . Influenza surveillance in Europe: comparing intensity levels calculated using the moving epidemic method. Influenza Other Respir Viruses. 2015; 9(5):234-46. PMC: 4548993. DOI: 10.1111/irv.12330. View

17.

Auburn H, Zuckerman M, Broughton S, Greenough A, Smith M . Detection of nine respiratory RNA viruses using three multiplex RT-PCR assays incorporating a novel RNA internal control transcript. J Virol Methods. 2011; 176(1-2):9-13. DOI: 10.1016/j.jviromet.2011.05.017. View

18.

Panozzo C, Stockman L, Curns A, Anderson L . Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis. Pediatrics. 2010; 126(1):e116-23. DOI: 10.1542/peds.2009-3221. View

19.

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Ambrose C . Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997-2012. Open Forum Infect Dis. 2017; 4(1):ofw270. PMC: 5414053. DOI: 10.1093/ofid/ofw270. View

20.

Amand C, Tong S, Kieffer A, Kyaw M . Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis. BMC Health Serv Res. 2018; 18(1):294. PMC: 5910575. DOI: 10.1186/s12913-018-3066-1. View